Given the concordance of the p63 regulated processes generated from our in-vitro cell line models, we proceeded to integrate the results from the cell-line based analysis (1350 genes) with the results from the HNSCC patient analysis (11 790 genes) to identify a common p63 gene signature. Here, TP63 is linked to head and neck squamous cell carcinoma.